Workshop UK-Mexico

Mitigating Emerging Infectious Challenges for Public Segurity and Justice

nov. 21 - 25, UNAM

Programa

[ 21 NOVEMBER ]

09:00 am

Antimicrobial Resistance Diagnostics Challenges (AMR DxC).

The World Health Organization (WHO) launched the first World Antibiotic Awareness Week 16th -22nd November 2015. WHO has established that antimicrobial resistance occurs when microorganisms such as bacteria, viruses, fungi and parasites change in ways that render the medications used to cure the infections they cause ineffective. When the microorganisms become resistant to most antimicrobials they are often referred to as “superbugs”. This is a major concern because a resistant infection may kill, can spread to others, and imposes huge costs to individuals and society.

The activities designed during event had been designed because it is considered that the AMR DxC event could bring possibilities, through a competition, for knowing and assuming the importance of the role for rapid diagnostics to tackle Antimicrobial Resistance. It is considered that the antimicrobial resistance and the development and introduction of innovative diagnostics could transform healthcare that need to involve collaboration across disciplines, countries, healthcare systems and economies. Innovation is also needed how the brightest minds can be attracted to the field. That is why AMR DxC is developed to galvanise the next generation of researchers into action. The objectives of AMR DxC are to connect and inspire fresh scientific talent, spark off ideas and create a network for international, interdisciplinary and innovative R&D on AMR diagnostics.

This event will give a overview of current research related to the field and also an opportunity to discover interesting connections. We are looking to identify well-defined research questions with probable solutions. These new questions might help to address long-standing questions of AMR Diagnostics.

AMR theme runs through the days of the workshop - these networking sessions are for all of our ECRs, where UK ECRs will be mixed with Mexico ECRs. It is an intention that there is a croos over all disciplines. The ECRs have to be presented each day for talks by senior researchers and to think about their activities and then present their ideas and solutions on the last day (saturday 25th November in the afternoon). This is sopporting the aim of the Newton Fund to get the ECRs talking together and thinking about problem solving aspects of AMR. 

 

 

 

[ 22 NOVEMBER ]

09:00 am

Dr. Jorge Méndez Galván

Opening and importance of the knowledge about the emerging and re-emerging infectious diseases.

Main opening ceremony. Aspects of the burden of emerging and re-emerging infectious disease, their health policy management and general aspects that could favour the appearance and maintenance of infectious diseases in Mexico.

 

[ 23 NOVEMBER ]

09:00 am

Arturo Reyes-Sandoval

Strategies for predicting and preventing the emerging and re-emerging infectious diseases.

The burden of emerging and re-emerging of specific infectious disease, their prediction and prevention and necessities for filling research gaps.

[ 24 NOVEMBER ]

09:00 am

Emerging infections in hospitals and antimicrobial resistance efforts.

Control of emerging infections in hospital and communities, AMR experiences in Mexico and health landscape for eradicating AMR

[ 25 NOVEMBER ]

09:00 am

Closing and perspectives of international collaborations for attending emerging and re-emerging infectious diseases and Closing of activities of ECRs in AMRDxC event.

Practical next steps for extending research collaborations between UK and Mexico. Point of views of different Mexican institutions that impulse those research collaborations in order to tackle the appearance, the diagnosis and the control of possible emerging and re-emerging infectious diseases. Conclusions and closing of the workshop.

Links of interest

Universidad Autonoma Nacional de Mexico

UNAM

La Universidad Nacional Autónoma de México ha desempeñado un papel destacado en la historia y formación de nuestro país. Las tareas sustantivas de esta institución pública, autónoma y secular son la enseñanza, la investigación y la difusión de la cultura. En el mundo académico es reconocida como una universidad de excelencia. La UNAM responde al presente y mira hacia el futuro como el proyecto cultural más importante de México. La UNAM es un espacio de libertades. En él, el respeto, la tolerancia y el diálogo se practican a diario. La pluralidad de ideas y pensamientos se aprecia como un signo de riqueza y nunca como un factor de debilidad.



 

THE UNIVERSITY OF EDINBURGH

LA UNIVERSIDAD DE EDIMBURGO

Después de la iluminación escocesa del siglo XVIII, la universidad se colocó en la vanguardia de la academia y el pensamiento crítico. Debido a la determinación y perseverancia de un grupo de intelectuales de Edimburgo, los hechos establecidos sobre el mundo fueron desafiados audazmente y consistentemente. En medio de este grupo estaba David Hume, filósofo, economista y ensayista conocido por su escepticismo filosófico y empirismo; Joseph Black, el químico detrás del descubrimiento del calor latente y del dióxido de carbono; y James Hutton, el "Padre de la Geología Moderna".




 

La Facultad de Medicina

Facultad de medicina

Misión
La Facultad de Medicina como parte de la Universidad Nacional Autónoma de México es una institución pública dedicada a capacitar a profesionales que son líderes en las ciencias de la salud, altamente calificados, capaces de generar investigación y difundir conocimientos. Sus programas están centrados en los estudiantes, promueven el aprendizaje auto-regulado y la actualización continua con énfasis en la conducta ética, el profesionalismo y el compromiso con la sociedad mexicana.
Visión
La Facultad de Medicina ejercerá el liderazgo intelectual y tecnológico en las ciencias de la salud. A nivel nacional e internacional, a través de la educación e investigación innovadora Aplicada al bienestar del ser humano.

Regístrate

 

Una estrategia de participar activamente para los asistentes al evento es la presentación de su trabajo de investigación que esté relacionado con el tópico del evento. Quienes se interesen deberán presentar su resumen y poster en inglés bajo las indicaciones siguientes: el poster deberá tener dimensiones de 90 x 90 cm, haber sido sometido el resumen (350 palabras que incluyan título, autores, dirección institucional y correo electrónico); la decisión final de la aceptación del resumen para presentar el postre será por parte del comité académico quien evaluará la calidad de lo propuesto y el tema bajo el cual podrá ser presentado. La fecha límite del sometimiento del resumen será en octubre 23.

Regístrate

Conferencistas

Jorge Tovar

Day 3

Dr Jorge Tovar Torres
Centre for Biomedical Sciences, Centre for Systems and Synthetic Biology. Imperial College of London, UK.

Dra. Gabriela Echaniz-Aviles

Day 4

Dra. Gabriela Echániz-Aviles
Coordinator of GIVEBPVac, a collaboration between INSP and hospitals throughout the country in a passive laboratory-based surveillance system for invasive bacterial pathogens which can be vaccine preventable. INSP, Cuernavaca, Mexico

Dra. Celia Alpuche

Day 3

Dra. Celia Alpuche
Director of Research Center for Infectious Diseases at the National Institute of Public Health, México.

Patricia Lozano Zarain

Day 4

Dr. Patricia Lozano Zarain
Researcher in the Laboratory of Infection Diseases for Hospitals and the Community, Research Centre in Microbiological Sciences, Sciences Institute from the Benemerita Autonomous University of Puebla, Mexico

Especialista en Medicina Interna y Enfermedades Infecciosas

Day 3

Dr. Hugo Lopez Gatell
Directo de Innovación en Vigilancia y Control de Enfermedades Infecciosas. Centro de Investigación sobre Enfermedades Infecciosas (CISEI) Instituto Nacional de Salud Pública. México

Expert in issues related to surgical site infections and other surgical-related outcomes. Infectious Diseases Dpt, INC, Mexico

Day 4

Dra. Diana Vilar-Compte
Researcher on issues related to surgical site infections and other surgical-related outcomes, hospital acquired infections, influenza, Clostridium difficile, and vaccination of adult patients with cancer.

Dr. Lilia González Cerón

Day 3

Dr. Lilia González Cerón
Researcher in Medical Sciences at the Regional Research Centre on Public Health of the National Institute of Public Health, Tapachula, Chiapas, Mexico.

Dr. Santiago Avila Ríos

Day 4

Dr. Santiago Avila Ríos
Researcher in medical sciences at the Centre for Research in Infectious Diseases (CIENI) of the National Institute of Respiratory Diseases (INER) in Mexico City